Patents Assigned to Optimus Drugs Private Limited
  • Patent number: 11702440
    Abstract: The present invention provides a crystalline and an amorphous form of a Molnupiravir and methods of making the crystalline form and amorphous form of Molnupiravir.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: July 18, 2023
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi
  • Patent number: 11312743
    Abstract: The present invention relates to a process for the preparation of Molnupiravir. The present invention also relates to an improved and commercially viable process for preparation of Molnupiravir with high yield and purity.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: April 26, 2022
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Venkata Gnaneswara Rao Guttikonda, Siva Reddy Desi Reddy
  • Patent number: 10077263
    Abstract: The present invention relates to an improved process for the preparation of Apixaban and its intermediates.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: September 18, 2018
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Patent number: 9676722
    Abstract: The present invention relates to an improved process for the preparation of Ivacaftor intermediates. The present invention is also provides industrial applicable, commercially and eco-friendly viable process for the preparation of Ivacaftor.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: June 13, 2017
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Patent number: 9643939
    Abstract: The present invention relates to an improved process for the preparation of Linezolid. More specifically, the present invention relates to an improved process for preparing (S)—N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] phthalimide and (S)-glycidyl phthalimide intermediates, which are used in the preparation of Linezolid.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: May 9, 2017
    Assignee: Optimus Drugs Private Limited
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela
  • Patent number: RE47606
    Abstract: The present invention relates to an improved process for the preparation of Linezolid. More specifically, the present invention relates to an improved process for preparing (S)—N-[[3-[3-fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl] phthalimide and (S)-glycidyl phthalimide intermediates, which are used in the preparation of Linezolid.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: September 17, 2019
    Assignee: OPTIMUS DRUGS PRIVATE LIMITED
    Inventors: Srinivas Reddy Desi Reddy, Subba Reddy Peketi, Dnyandev Ragho Rane, Venkata Srinivasa Rao Velivela